Trends Immunol. 2025 May 26:S1471-4906(25)00122-X. doi: 10.1016/j.it.2025.05.001. Online ahead of print.
ABSTRACT
Microglia replacement is reshaping neurodegenerative disease therapy, yet its key prerequisites remain unclear. In the current issue of Immunity, Aisenberg et al. and Bastos et al. reveal how developmental origin influences monocyte engraftment into the brain, and demonstrate the therapeutic potential of monocyte-based interventions in a monogenic neurological disease.
PMID:40425373 | DOI:10.1016/j.it.2025.05.001